Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by Kooleron Aug 09, 2010 2:13pm
627 Views
Post# 17334373

RE: RE: RE: RE: RE: Upgrade

RE: RE: RE: RE: RE: Upgrade
there, i hope the cut and paste works this time.

Resverlogix Corp RVX
Performance
Growth of $10,000 08-06-10
Total Return% 2007 2008 2009 YTD
Stock -5.2 -86.0 18.6 9.5
+/- Industry -5.9 -61.8 48.8 -22.4
+/- S&P 500 -8.7 -47.5 -4.8 8.9
Key Stats
Last Close (08-06-10) $2.65
Market Cap $Mil 74
Sales $Mil 0
Morningstar Style Box Small Core
Industry Diversified Investments
Sector Financial Services
Stock Type
Morningstar Stock Grades
Growth B
Profitability F
Financial Health B
Valuation 12-11-09
Stock Industry S&P 500
Price/Earnings -3.7 16 20.0
Forward P/E -6.9 14.4 15.9
Price/Book 7.8 1.8 2.2
Price/Cash Flow -4.8 9 7.2
Price/Sales 1000.0 1.6 1.2
Dividend Yield % --- 4.7 2.1
S&P 500 data through 12-11-09
Growth 04-30-09
1 Year%
3 Year%
S&P 500
Sales -84.6 -15.4 -1.7
Net Income --- --- ---
EPS --- --- -10.7
Equity/Share 129.1 10.5 -0.4
Dividends --- --- 16.0
S&P 500 data - 3 Year%
Profitability 07-31-09
Stock Industry S&P 500
ROA % -131.4 6.8 6.2
ROE % -364.0 11.5 15.8
Net Margin % -27396.7 10 8.3
Asset Turnover 0.0 67.7 0.8
Fin Leverage 1.7 1.6 5.6
Sales/Employee
$Thousands
3.1 --- ---
Stock uses trailing 12 months. Industry and S&P 500 use fiscal year-end.
Earnings Trends 07-31-09
Historical years use fiscal year-end.
* Estimated
Fund Ownership
% Shares Held % Fund Assets Star Rating
0.07 0.17 1 stars
0.02 0.01 4 stars
0 0 3 stars
Company Profile
Resverlogix Corp RVX
Operations
What Does This Company Do?
Address 279 Midpark Way SE
Suite 202
Calgary, AB T2X 1M2
Phone 1 403 254-9252
Website https://www.resverlogix.com
Direct Investment ---
Dividend Reinvestment ---
Employees 26
Industry Peers
Resverlogix Corp RVX
Industry Peers
Morningstar Stock Grades
Stock Mkt Cap $Mil Sales $Mil Growth Profit-
ability
Financial
Health
Resverlogix Corp 74 0 B F B
Industry Average 1,229 1,103 C+ D+ C
Allianz SE 56,088 120,684 D D ---
Unicredit SpA 51,763 39,622 C C ---
Axa SA 47,884 95,537 D D ---
Hong Kong Exchanges and Clearing Ltd. 45,134 833 B A ---
BOC Hong Kong (Holdings) Ltd. 24,397 3,309 C C ---
CME Group Inc 22,195 2,637 B D C
Jardine Matheson Holdings Limited 18,408 22,362 A C ---
Deutsche Borse AG 14,417 3,772 C A ---
First Pacific Company, Ltd. 9,447 3,075 C D ---
IntercontinentalExchange, Inc. 8,021 945 A B C
NYSE Euronext 6,682 4,773 D D C
GuocoLeisure Limited 5,746 529 B D ---
Swedbank AB 5,308 5,512 --- --- ---
NASDAQ OMX Group, Inc. 4,150 3,617 B C C
MSCI, Inc. 3,304 432 C B B
GAM Holding AG 2,342 2,793 --- C ---
PetroAlgae, Incorporated 2,170 0 --- --- D
Acom Company Limited 2,107 3,141 --- F ---
Apollo Investment Corporation 1,626 350 B F ---
Ares Capital Corporation 1,294 239 B D ---
Pearl Group 1,237 0 --- --- A
Industry Average is equal-weighted.
Mkt Cap as of 2009-12-11.
Sales TTM through most recent quarter-end.
Grades through 2009-11-30.
Growth
Resverlogix Corp RVX
Growth Grade: B
Fiscal year-end: 4 2006 2007 2008 2009
Sales % 23.3 18.0 234.3 -84.6
Earnings/Share % --- --- --- ---
Book Value/Share % -34.9 --- --- 129.1
Dividends/Share % --- --- --- ---
Profitability
Resverlogix Corp RVX
Fiscal year-end: 4 TTM=Trailing 12 Months
2005 2006 2007 2008 2009 TTM
Return on Assets % -43.2 -65.2 -143.1 -151.3 -99.4 -131.4
Industry 4.7 6.6 7.3 5.2 --- 6.8
Return on Equity % -45.1 -68.8 -507.1 -1302.1 -223.4 -364.0
Industry 8.2 12.5 13.6 8.1 --- 11.5
ROE Breakdown
Net Margin% -1620.8 -2620.1 -5707.1 -2642.7 -13101.8 -27396.7
Asset Turnover 0.0 0.0 0.0 0.1 0.0 0.0
Financial Leverage 1.0 1.1 --- 3.8 1.6 1.7
Financial Health
Resverlogix Corp RVX
Fiscal year-end: 4 Qtr = Current Quarter
2005 2006 2007 2008 2009 Qtr
Long-Term Debt $Mil --- 0 15 12 0 ---
Total Equity $Mil 12 8 -1 5 14 10
Debt/Equity --- --- --- 2.2 --- ---
S&P 500 0.8 0.7 1.1 1.0 --- 0.9
Financial Leverage 1.0 1.1 --- 3.8 1.6 1.7
S&P 500 4.0 3.9 4.3 4.6 --- 5.6
Current Ratio Infinity 8.0 4.7 6.3 2.3 2.1
S&P 500 1.9 1.8 1.7 1.8 --- 2.0
Valuation Ratios
Resverlogix Corp RVX
Valuation Ratios 12-11-09
Stock Industry S&P 500 Stock's 5Yr Average*
Price/Earnings -3.7 16 20.0 ---
Price/Book 7.8 1.8 2.2 ---
Price/Sales 1000.0 1.6 1.2 ---
Price/Cash Flow -4.8 9 7.2 ---
Dividend Yield % --- 4.7 2.1 ---
* Price/Cash Flow uses 3-year average.
5-Yr Financials (restated)
Resverlogix Corp RVX
Fiscal year-end: 4 TTM = Trailing 12 Months

2005 2006 2007 2008 2009 TTM
Sales $Mil 0 0 0 1 0 0
Operating Income $Mil -4 -7 -18 -28 -23 -24
Income Tax $Mil --- --- --- --- --- ---
Net Income $Mil -4 -7 -18 -28 -22 -22
Earnings/Share $ -0.17 -0.30 -0.76 -1.10 -0.73 -0.67
EPS (Cont Ops) $ -0.20 -0.30 -0.80 -1.10 -0.70 -0.70
Dividends/Share $ 0.00 0.00 0.00 0.00 0.00 0.00
Total Shares Mil 21 24 24 26 30 33
Cash Flow $Mil
Fiscal year-end: 4 TTM = Trailing 12 Months
2007 2008 2009 TTM
Operating Cash Flow -11 -20 -16 -17
Capital Spending 1 0 0 0
Free Cash Flow -12 -20 -16 -17
Balance Sheet
Assets $Mil
Cash 8.0
Other Current Assets 7.0
Long-Term Assets 1.0
Total 16.7
Liabilities and Equity $Mil
Current Liabilities 7.2
Long-Term Liabilities 0.0
Shareholders' Equity 9.5
Total 16.7
Quarterly Results
Resverlogix Corp RVX
Quarterly Income
Sales 10-08 01-09 04-09 07-09
Current $Mil 0.0 0.0 0.0 0.0
% Change From Year Earlier -80.60 -96.60 -99.80 -99.20
Net Income
Current $Mil -6.0 -6.0 -4.0 -5.0
% Change From Year Earlier --- --- --- ---
Earnings/Share
Current $ -0.20 -0.26 -0.12 -0.14
% Change From Year Earlier --- --- --- ---
Returns
Resverlogix Corp RVX
Data as of 08-06-10
Last Close 52-Week Range 5 Year Range
$2.65 $2.10 - $8.20 $1.50 - $29.50
1 Month Range % Below 52-Week High % Below 5 Year High
$2.60 - $2.90 67.68 91.02
Total Returns % Data through 08-06-10
2005 2006 2007 2008 2009 YTD
Stock 47.8 126.5 -5.2 -86.0 18.6 9.5
+/- Industry 65.1 129.2 -5.9 -61.8 48.8 -22.4
+/- S&P 500 44.8 112.9 -8.7 -47.5 -4.8 8.9
Trailing Total Returns 1 Month 3 Month 1 Year 3 Yr Avg 5 Yr Avg 10 Yr Avg * YTD
Stock -1.5 -51.5 -5.0 -33.7 -17.1 --- 9.5
+/- Industry -4.6 -62.4 -34.9 -23.9 -9.7 --- -22.4
+/- S&P 500 -10.6 -50.9 -17.5 -25.1 -15.3 --- 8.9
*data through 07-31-10
Price/Dividends/Splits
Dividend History 12-05 12-06 12-07 12-08 12-09
Dividend $ --- --- --- --- ---
Year-end Yield % --- --- --- --- ---
S&P 500 Yield % 1.76 1.70 1.81 3.17 ---
5 Year History Splits and Dividends Amount Per Share
Growth of $10,000 YTD through 08-06-10
Stock: Resverlogix Corp
Industry: Diversified Investments
Index: S&P 500
Total Returns % 2005 2006 2007 2008 2009 YTD
Stock 47.8 126.5 -5.2 -86.0 18.6 9.5
+/- Industry 65.1 129.2 -5.9 -61.8 48.8 -22.4
+/- S&P 500 44.8 112.9 -8.7 -47.5 -4.8 8.9
Wall St. Estimates
Resverlogix Corp RVX
Annual Earnings Estimates Data through last Friday
04-10 04-11
$ Growth % $ Growth %
High -0.57 --- -0.20 ---
Low -0.64 --- -0.50 ---
Mean -0.61 --- -0.35 ---
30 Days Ago -0.61 --- -0.35 ---
60 Days Ago -0.57 --- -0.20 ---
90 Days Ago -0.57 --- -0.20 ---
Number of Estimates 2.00 2.00
Five Year Growth Forecast: --- %
Industry Average: 12.6 %
Data through last Friday
Average Rating Last Month Industry Average S&P 500 Average
1.0 0.0 1.55 1.46
1=Buy 3=Sell
Forward Comparisons
Next 5 Years' Estimated Growth% Forward P/E PEG Ratio
Stock --- -6.9 ---
Industry 12.6 14.4 1.1
S&P 500 10.7 15.9 1.8
Top Fund Owners
Resverlogix Corp RVX
Top Fund Owners
Fund Name Star
Rating
% of Shares
Held
% of Fund
Assets
Change (000)
in Ownership
Date of
Portfolio
Sprott Growth 1 stars 0.07 0.17 26 03-31-10
DFA Canadian Core Equity A 4 stars 0.02 0.01 0 04-30-10
iShares S&P/TSX SmallCap Index 3 stars 0 0 -10.35 06-30-10
# of Shares
Shares Outstanding 39,358,002
Fund Ownership 34
Total# of Funds 3
Average Star Rating 2.7
SEC Filings
Resverlogix Corp RVX
© Copyright 2009 Morningstar, Inc. All rights reserved. Not to be redistributed without written permission. To order reprints call 312-696-6100.
Bullboard Posts